NASDAQ: BTSGBrightspring Health Services Inc Stock
$61.00+1.78 (+3.01%)
Updated Jun 9, 2026
BTSG Price
$61.00
Fair Value Price
$2.20
Market Cap
$11.83B
52 Week Low
$19.01
52 Week High
$62.10
P/E
40.13x
P/B
5.98x
P/S
0.64x
PEG
1.97x
Dividend Yield
N/A
Revenue
$13.65B
Earnings
$309.89M
Gross Margin
12.2%
Operating Margin
3.71%
Profit Margin
2.3%
Debt to Equity
2.13
Operating Cash Flow
$512M
Beta
1.1
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BTSG Overview
BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BTSG's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
BTSG
Ranked#6 of 45
Ranked#6 of 45
Be the first to know about important BTSG news, forecast changes, insider trades & much more!
BTSG News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BTSG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BTSG ($61.00) is overvalued by 2,678.05% relative to our estimate of its Fair Value price of $2.20 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BTSG ($61.00) is not significantly undervalued (2,678.05%) relative to our estimate of its Fair Value price of $2.20 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BTSG ($61.00) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BTSG due diligence checks available for Premium users.
Valuation
BTSG fair value
Fair Value of BTSG stock based on Discounted Cash Flow (DCF)
Price
$61.00
Fair Value
$2.20
Overvalued by
2,678.05%
BTSG ($61.00) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BTSG ($61.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BTSG ($61.00) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
BTSG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
40.13x
Industry
15.18x
Market
14.33x
BTSG is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BTSG is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
BTSG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.98x
Industry
3.11x
BTSG is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BTSG price to earnings growth (PEG)
For valuing profitable companies with growth potential
BTSG is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
BTSG's financial health
Profit margin
Revenue
$3.6B
Net Income
$148.8M
Profit Margin
4.1%
BTSG's Earnings (EBIT) of $505.99M... subscribe to Premium to read more.
Interest Coverage Financials
BTSG's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.2B
Liabilities
$4.2B
Debt to equity
2.13
BTSG's short-term assets ($2.69B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BTSG's short-term assets ($2.69B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BTSG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$122.9M
Investing
$747.4M
Financing
-$70.0M
BTSG's operating cash flow ($511.51M)... subscribe to Premium to read more.
Debt Coverage Financials
BTSG vs Health Information Service Stocks
Brightspring Health Services Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.